Photo taken from Mass General Cancer Center/X
Aug 28, 2024, 05:03
Individualized cancer therapy boosts immune activity – Mass General Cancer Center
Mass General Cancer Center shared a post on X:
“A study led by researchers at Mass General Cancer Center found that an individualized cancer therapy tailored to the unique tumor profiles of patients with melanoma and lung cancer was well-tolerated and boosted immune activity.”
Individualized Cancer Therapy Demonstrates Safety and Sustained Immune Responses published in Massachusetts General Hospital.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 4, 2025, 09:26
Sep 4, 2025, 08:36
Sep 4, 2025, 08:36
Sep 4, 2025, 08:27
Sep 4, 2025, 08:13